Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
AbbVie’s IL-23 blocker shows efficacy in psoriasis trial
An experimental therapy being developed by AbbVie for the treatment of patients with moderate to severe plaque psoriasis has hit key targets in a pivotal late-stage trial.
BRIEF—Gilead announces public health initiative to combat HIV/AIDS in southern USA
Gilead Sciences has announced the launch of a 10-year, $100 million commitment to support organizations combatting the HIV/AIDS epidemic in the Southern United States.
Active Biotech announce results in ARPEGGIO Phase II trial with laquinimod in Primary Progressive MS
Active Biotech (Nasdaq Stockholm.
Researchers identify medication that can prevent migraines
An antibody therapy against key inflammatory molecule involved in migraines reduces the number of headaches in chronic migraine patients.
Astellas buys DMD drug in $450M mitochondrial takeover
Astellas has acquired its partner Mitobridge in a deal worth up to $450 million.
Preventing psoriasis with vanillin
Small amounts of artificial vanilla extract, also known as vanillin, are in a wide range of products, from baked goods to perfumes.
Sanofi ends development of C. difficile vaccine
(Reuters) - Pharmaceutical company Sanofi SA said on Friday that it had ended development of an experimental vaccine for Clostridium difficile infection, after an early look at late-stage tria...
Newfound protein may prevent viral infection and herpes-induced cancer
USC-led study sketches a disease roadmap for a soft tissue cancer called Kaposi sarcomaKeck School of Medicine of USC researchers have identified a human protein that could prevent cancer by restricti...
Could J&J's Darzalex success spur it to buy out partner Genmab? Maybe so, one analyst says
Wednesday, multiple myeloma med Darzalex hit a development milestone, triggering a $20 million payment from Johnson & Johnson for Genmab.
Mylan and Biocon win FDA nod for Herceptin copy and move biosim forward in EU
Mylan and Biocon today became the first drugmakers to win an FDA approval of a biosimilar of Roche's blockbuster cancer drug Herceptin, a med that raked in $2.
FDA clears first medical device accessory for Apple Watch
(Reuters) - The U.
FDA Approves Ferring's CLENPIQ™ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep
PARSIPPANY, NJ, USA I November 29, 2017 I The U.
472
473
474
475
476
477
478
479
480
